Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate (Q38352468)

2 September 2017

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate (English)

1 reference

2 September 2017

0 references

1 reference

5

Robert J Linhardt

1 reference

2 September 2017

13

Thomas F Baumert

1 reference

2 September 2017

1

Heidi Barth

1 reference

2 September 2017

Christiane Schafer

2

1 reference

2 September 2017

Mohammed I Adah

3

1 reference

2 September 2017

Fuming Zhang

4

1 reference

2 September 2017

Hidenao Toyoda

6

1 reference

2 September 2017

Akiko Kinoshita-Toyoda

7

1 reference

2 September 2017

Toshihiko Toida

8

1 reference

2 September 2017

Toin H Van Kuppevelt

9

1 reference

2 September 2017

Erik Depla

10

1 reference

2 September 2017

Fritz Von Weizsacker

11

1 reference

2 September 2017

Hubert E Blum

12

1 reference

2 September 2017

language of work or name

English

0 references

publication date

16 July 2003

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

278

1 reference

2 September 2017

41003-41012

1 reference

2 September 2017

42

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Hepatitis C virus: detection of intracellular virus particles by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The role of the hepatitis C virus glycoproteins in infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Hepatitis C virus-like particle morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Human papillomavirus infection requires cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

A putative cellular receptor for dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

A model for the hepatitis C virus envelope glycoprotein E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Cell fusion activity of hepatitis C virus envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Sensitive high-performance liquid chromatographic method with fluorometric detection for the determination of heparin and heparan sulfate in biological samples: application to human urinary heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Chemical microdetermination of heparin in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

"Fast moving" and "slow moving" heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

Molecular modeling of protein-glycosaminoglycan interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302267200

21 January 2018

Identifiers

DOI

10.1074/JBC.M302267200

1 reference

2 September 2017

1 reference